3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Withdrawn
1
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
220
Urinary Bladder Neoplasms
54
Carcinoma, Renal Cell
52
Neoplasms
27
Non-Muscle Invasive Bladder Neoplasms
26
Kidney Neoplasms
25
Breast Neoplasms
17
Carcinoma, Transitional Cell
16
Adenocarcinoma
15
Melanoma
11
Disease
11
Neoplasm Metastasis
10
Colorectal Neoplasms
10
Uterine Cervical Neoplasms
9
Endometrial Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Stomach Neoplasms
7
Ovarian Neoplasms
7
Lung Neoplasms
7
Triple Negative Breast Neoplasms
6
Testicular Neoplasms
6
Recurrence
6
Clear-cell metastatic renal cell carcinoma
6
Urologic Neoplasms
5
Urinary Incontinence
5
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Pancreatic Neoplasms
5
Head and Neck Neoplasms
5
Carcinoma, Hepatocellular
5
Interventions
TH 302
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Castration Resistant Prostate Cancer
×
Genitourinary
×
Clear all
NCT06836726
2026-01-28
EVO
University Health Network, Toronto
Phase 2
Not yet recruiting
35 enrolled